Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

On Drug Price Increases, Pfizer's Read Expects ‘Business As Normal’ In 2019

Oct 30 2018

• By Jessica Merrill

Ladder made of coins with colorful pills on top suggesting the growing prices of medicine or drugs

Related Content

HHS Advancing Attack On Rebates With Proposal To Revoke Safe Harbor

Jul 25 2018

Pfizer Agrees To Roll Back Prices On 40 Drugs, Yielding To Pressure From Trump

Jul 11 2018

Who's Promised What: A Guide To Pharma Drug Pricing Pledges

Jul 23 2018

10 Things For Pfizer's New CEO To Worry About

Oct 16 2018

Medicare's Foreign Price Bench-marking Will Only Hurt Bad Negotiators, HHS's Azar Argues

Oct 26 2018

Pfizer CEO Read Will Pass The Torch To Bourla In 2019

Oct 01 2018

Pfizer Agrees To Roll Back Prices On 40 Drugs, Yielding To Pressure From Trump

Jul 11 2018

Related Companies

Pfizer Inc.

Additional Topics

United States Pricing Debate Reimbursement Government Payers Sales & Earnings Business Strategies Policy BioPharmaceutical

More from Pricing Debate

More from Market Access

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window